Status:
UNKNOWN
CD4+ T Cells and S100A7 Epression in Normal and Psoriatic Skin: A Histological and Histochemical Study
Lead Sponsor:
Sohag University
Conditions:
Psoriasis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Psoriasis is one of the commonest and most researched chronic immune-mediated inflammatory skin disorders that affects approximately 1-3% of the population worldwide and significantly impairs patients...
Eligibility Criteria
Inclusion
- the study will include patients with psoriasis
Exclusion
- pregnancy
- lactation
Key Trial Info
Start Date :
September 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06050330
Start Date
September 30 2023
End Date
September 30 2024
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt